Related Experiment Video

Updated: Jul 19, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Optimizing the pharmacologic treatment of hypertension: BP control and target organ protection

Peter M Nilsson1

  • 1Department of Clinical Sciences Medicine, University Hospital, Lund University, Malmö, Sweden. Peter.Nilsson@med.lu.se

American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|November 7, 2006
PubMed

Insights

Hypertension management requires effective drug combinations to reduce cardiovascular disease (CVD) risk. Newer agents like ACE inhibitors and ARBs offer improved options alongside traditional therapies for better blood pressure control.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Hypertension is a major risk factor for cardiovascular disease (CVD), contributing significantly to global health burdens.
  • Effective blood pressure (BP) control is crucial for reducing CVD risk, yet remains suboptimal in many patients.
  • Current guidelines emphasize comprehensive risk factor management in hypertensive individuals.

Purpose of the Study:

  • To review current hypertension treatment strategies, focusing on combination therapy for cardiovascular risk reduction.
  • To evaluate the evolving role of different drug classes, including newer agents and traditional medications.
  • To discuss the evidence base for drug combinations in achieving optimal BP control and target organ protection.

Main Methods:

  • Literature review of hypertension treatment guidelines and clinical trial data.
  • Analysis of the efficacy and safety profiles of various antihypertensive drug classes.
  • Examination of evidence supporting synergistic and cost-effective drug combinations for hypertension management.

Main Results:

  • Conventional drugs like thiazide diuretics remain important, while newer agents such as calcium channel antagonists and ACE inhibitors are valuable for monotherapy and combination therapy.
  • The role of beta-blockers has shifted; they are less recommended for primary prevention but still indicated for secondary prevention and combination therapy.
  • Angiotensin II type 1 receptor antagonists (ARBs) show promise, though their comparative efficacy against ACE inhibitors for cardiovascular protection is debated.

Conclusions:

  • Achieving adequate BP control necessitates a multi-faceted approach, including the judicious use of evidence-based drug combinations.
  • Optimizing hypertension treatment requires considering synergistic drug combinations that are both effective and cost-efficient.
  • Continued research is needed to refine treatment strategies and address the unmet needs in managing hypertensive patients and their associated CVD risks.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...